Top Markets
Coin of the day
OptiNose, Inc. OptiNose, Inc.

OptiNose, Inc.

OPTN
Rankning i aktier #9145
OptiNose, Inc. is a specialized pharmaceutical company primarily focused on... OptiNose, Inc. is a specialized pharmaceutical company primarily focused on innovating and bringing to market treatments for individuals under the care of ear, nose, throat, and allergy specialists throughout the United States. Its flagship product, XHANCE, utilizes the company's proprietary exhalation delivery system (EDS) to administer a topically-acting corticosteroid. This therapy is approved for treating chronic rhinosinusitis when accompanied by nasal polyps and is currently undergoing Phase IIIb clinical trials for broader chronic sinusitis treatment. The company also offers Onzetra Xsail, a powder-based EDS device, which is commercialized via a licensing agreement with Currax Pharmaceuticals LLC. Further expanding its pipeline, OptiNose is developing OPN-019, an investigational product that integrates a liquid EDS device with an antiseptic agent. Additionally, OptiNose has formed a partnership with Inexia Limited. This collaboration centers on the development, manufacturing, importation, and sale of products containing orexin receptor agonist or positive modulator molecules, intended for the treatment, diagnosis, or prevention of human conditions predominantly linked to orexin receptor activity. Established in 2000, OptiNose, Inc. operates from its corporate headquarters in Yardley, Pennsylvania.
Aktiekurs
$9.60
Senast synkroniserad: 2025-05-21
Marknadsvärde
$1.08B
Förändring (1 dag)
0.00%
Förändring (1 år)
0.00%
Land
US
Handel OptiNose, Inc. (OPTN)

Kategori

EPS för OptiNose, Inc. (OPTN)
EPS per March 2025 TTM: $-2.67
Enligt OptiNose, Inc.s senaste finansiella rapporter och aktiekurs är bolagets nuvarande EPS (TTM) $-2.67. Vid slutet av 2023 hade bolaget ett EPS på $-0.32, en minskning jämfört med EPS från 2022 som var $-13.05.
EPS-historik för OptiNose, Inc. från 2015 till 2026
EPS vid slutet av varje år
År EPS Ändra
2026 (TTM) $-2.67 25.94%
2024 $-2.12 562.50%
2023 $-0.32 -97.55%
2022 $-13.05 806.25%
2021 $-1.44 -29.41%
2020 $-2.04 -21.54%
2019 $-2.60 -2.99%
2018 $-2.68 83.56%
2017 $-1.46 -505.56%
2016 $0.36 -108.39%
2015 $-4.29 0.00%
EPS för liknande företag eller konkurrenter